LVTX

LAVA Therapeutics NV News

Company Name Stock Ticker Symbol Market Type
LAVA Therapeutics NV LVTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.56 8.3% 7.31 17:00:44
Open Price Low Price High Price Close Price Prev Close
6.50 6.30 7.35 7.31 6.75
more quote information »

Recent News

Date Time Source Heading
11/16/202217:11EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/16/202216:05GLOBELAVA Therapeutics Provides Business Update and Reports Third..
11/03/202216:05GLOBELAVA Therapeutics to Present at the Jefferies London..
11/03/202209:00GLOBELAVA Therapeutics to Present Updated Data from the Phase..
11/01/202207:00GLOBELAVA Therapeutics Announces Appointment of Fred M. Powell as..
10/07/202211:00GLOBELAVA Therapeutics to Present On-Mechanism Pharmacodynamics..
10/03/202216:16EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
9/30/202216:46EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
9/30/202216:11EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/27/202223:41TRMNAnalysts’ Opinions Are Mixed on These Healthcare Stocks:..
9/26/202212:55TRMNJMP Securities Keeps Their Buy Rating on LAVA Therapeutics..
9/26/202208:00GLOBESeagen and LAVA Therapeutics Announce Exclusive Worldwide..
9/15/202200:25TRMNLAVA Therapeutics (LVTX) Has a New Rating from JMP..
9/13/202216:05GLOBELAVA Therapeutics Provides Business Update and Reports..
9/07/202207:41GLOBELAVA Therapeutics to Present at the H.C. Wainwright 24th..
6/16/202216:05GLOBELAVA Therapeutics Highlights Encouraging Clinical Updates on..
6/15/202207:00GLOBELAVA Therapeutics Announces Two Appointments to its Board of..
6/06/202211:00TRMNJ.P. Morgan Thinks LAVA Therapeutics’ Stock is Going to..
6/02/202217:31EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
6/02/202207:00GLOBELAVA Therapeutics to Participate at the Jefferies Healthcare..
6/01/202207:00GLOBELAVA Therapeutics to Present Initial Phase 1/2a Clinical..
5/31/202216:05GLOBELAVA Therapeutics Announces Annual Meeting of Shareholders
5/18/202223:48TRMNLAVA Therapeutics (LVTX) Gets a Buy Rating from SVB..
5/17/202207:00GLOBELAVA Therapeutics Provides Business Update and Reports First..
5/12/202207:00GLOBELAVA Therapeutics Announces FDA IND Clearance for LAVA-051..
5/05/202207:00GLOBELAVA Therapeutics to Participate at the UBS Global..
5/02/202211:30TRMNLeerink Partners Thinks LAVA Therapeutics’ Stock is Going to..
4/27/202210:05GLOBELAVA Therapeutics to Present Updated LAVA-051 Clinical Data..
4/22/202206:16EDGARNotice of Effectiveness (effect)
4/12/202216:03EDGARSecurities Registration (foreign Private Issuer) (f-3)
3/28/202216:05EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/24/202211:11EDGARAnnual and Transition Report (foreign Private Issuer) (20-f)
3/24/202207:10SEEKLAVA Therapeutics GAAP EPS of -$0.38 misses by $0.01,..
3/24/202206:30GLOBELAVA Therapeutics Provides Business Update and Reports..
3/10/202206:30GLOBELAVA Therapeutics To Present at the Oppenheimer 32nd Annual..
3/07/202208:35GLOBELAVA Therapeutics Presents Initial LAVA-051 Clinical Data at..
2/01/202208:22SEEKLava Therapeutics begins dosing in phase 1/2a trial of..
2/01/202206:30GLOBELAVA Therapeutics Announces Treatment of First Patient in..
1/28/202207:00GLOBELava Therapeutics Announces Participation in the SVB Leerink..
1/18/202208:30GLOBELAVA Therapeutics Presents Preclinical Data on its..
1/08/202207:06TRMNAnalysts Offer Insights on Healthcare Companies: Argenx Se..
1/07/202211:00EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/20/202110:06GLOBECORRECTING AND REPLACING - LAVA Therapeutics to Present..
12/20/202107:00GLOBELAVA Therapeutics to Present Corporate Overview at 40th..